Primary Job Title Co-Founder, President and CEO Primary Organization PAQ Therapeutics
Location Greater Boston Area, United States, North America Regions East Coast, New England Gender Male
LinkedIn View on LinkedIn
Nan Ji is President and CEO of PAQ Therapeutics. He co-founded the company with Boxun Lu and Huaixiang Hao during the height of the COVID-19 pandemic, channeling his time and energy into the pursuit of realizing the full potential of targeted degradation. Dr. Ji is a prolific inventor and discoverer, with more than 30 patent applications filed.
With three years spent at Kymera Therapeutics from the time the company was in its initial seed stage, he is also an expert at building an organization from the ground up. At Kymera, Dr. Ji served as Vice President of Chemistry and played significant roles in driving the company scientific strategies, platform-building activities, business development, as well as external collaborations crucial to the company’s success in targeted protein degradation technology. Before Kymera, he spent 2 years at Mitobridge (now part of Astellas), where he was responsible for its NAD+-boosting portfolio with multiple approaches to modulate mitochondrial functions. Prior to that, Nan spent 7+ years at Novartis, where he contributed to and delivered multiple clinical and preclinical development candidates. Dr. Ji earned his PhD in Organic Chemistry at Harvard University.
